You are here:
calcium acetate (Phoslo)
Advice
Following an abbreviated submission
calcium acetate (PhosLo) is accepted for use in NHS Scotland for prevention/treatment of hyperphosphataemia in patients with advanced renal failure on dialysis.
For patients in whom calcium acetate is an appropriate phosphate binding agent this product is available at a cost per unit of calcium equivalent to that of an existing preparation.
Drug Details
| Drug Name: | calcium acetate (Phoslo) |
|---|---|
| SMC Drug ID: | 601/10 |
| Manufacturer: | Fresenius Medical Care (UK) Ltd |
| Indication: | hyperphosphataemia |
| BNF Category: | |
| Sub Category: | 9.5 Minerals |
| Submission Type: | Abbreviated Submission |
| Status: | Accepted |
| Date Advice Published: | 8 February 2010 |